Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Pan, Diao"'
Autor:
Pan Diao, Yaping Wang, Fangping Jia, Xiaojing Wang, Xiao Hu, Takefumi Kimura, Yoshiko Sato, Kyoji Moriya, Kazuhiko Koike, Jun Nakayama, Naoki Tanaka
Publikováno v:
Liver Cancer (2022)
Introduction: Previous research has demonstrated that an isocaloric diet rich in trans fatty acid (TFA), saturated fatty acid (SFA), and cholesterol (Chol) promoted steatosis-derived hepatic tumorigenesis in hepatitis C virus core gene transgenic (HC
Externí odkaz:
https://doaj.org/article/c5c9f38edb9c40c6a0b4fda2c9ff50fe
Autor:
Xuguang Zhang, Pan Diao, Hiroaki Yokoyama, Yoshiki Inoue, Kazuhiro Tanabe, Xiaojing Wang, Chihiro Hayashi, Tomoki Yokoyama, Zhe Zhang, Xiao Hu, Takero Nakajima, Takefumi Kimura, Jun Nakayama, Makoto Nakamuta, Naoki Tanaka
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
Obesity is becoming a major public health problem worldwide. Making charcoal from wood (“Sumi-yaki”) has been a traditional activity in the southern part of Nagano Prefecture for centuries, with activated charcoal having reported detoxifying effe
Externí odkaz:
https://doaj.org/article/ae24d0a73fb64674b2e1c44abbf32ccc
Autor:
Fangping Jia, Pan Diao, Xiaojing Wang, Xiao Hu, Takefumi Kimura, Makoto Nakamuta, Ibuki Nakamura, Saki Shirotori, Yoshiko Sato, Kyoji Moriya, Kazuhiko Koike, Frank J. Gonzalez, Jun Nakayama, Toshifumi Aoyama, Naoki Tanaka
Publikováno v:
Liver Cancer, Pp 1-20 (2020)
Background and Aims: Dietary restriction (DR) is a preventive strategy for obesity, metabolic syndrome, cardiovascular disease, and diabetes. Although an interconnection between obesity, metabolic syndrome, fatty liver, and hepatocellular carcinoma h
Externí odkaz:
https://doaj.org/article/795e58f0c4294ea8af46115a00b0ebec
Autor:
Momoko Hayashi, Yoshibumi Kuwabara, Kuniji Ito, Yoshiaki Hojo, Fumiaki Arai, Kazuki Kamijima, Masakazu Takeiri, Xiaojing Wang, Pan Diao, Jun Nakayama, Naoki Tanaka
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 384 (2023)
Non-alcoholic steatohepatitis (NASH) is a chronic liver disease which may progress into liver fibrosis and cancer. Since NASH patients have a high prevalence of atherosclerosis and ensuing cardiovascular diseases, simultaneous management of NASH and
Externí odkaz:
https://doaj.org/article/0ccaabae992740a18ed63249b24de81e
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1667 (2022)
Pemafibrate (PEM) is a novel lipid-lowering drug classified as a selective peroxisome proliferator-activated receptor α (PPARα) modulator whose binding efficiency to PPARα is superior to that of fibrates. This agent is also useful for non-alcoholi
Externí odkaz:
https://doaj.org/article/40c8830a3ccf474f9728eb28cc6d9bd2
Autor:
Pan Diao, Yaping Wang, Fangping Jia, Xiaojing Wang, Xiao Hu, Takefumi Kimura, Yoshiko Sato, Kyoji Moriya, Kazuhiko Koike, Jun Nakayama, Naoki Tanaka
Publikováno v:
Liver Cancer. 12:57-71
Introduction: Previous research has demonstrated that an isocaloric diet rich in trans-fatty acid (TFA), saturated fatty acid (SFA), and cholesterol (Chol) promoted steatosis-derived hepatic tumorigenesis in hepatitis C virus core gene transgenic (HC
Autor:
Qianqian Zheng, Masaya Kawaguchi, Hayato Mikami, Pan Diao, Xuguang Zhang, Zhe Zhang, Takero Nakajima, Takanobu Iwadare, Takefumi Kimura, Jun Nakayama, Naoki Tanaka
Non-alcoholic steatohepatitis (NASH), which is the most severe manifestation of non-alcoholic fatty liver disease (NAFLD), has been recognized as a major hepatocellular carcinoma (HCC) catalyst. However, the molecular mechanism of NAFLD-NASH-HCC sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cd555783c89f2ed6b486ed7d872a0b2
https://doi.org/10.20944/preprints202305.0075.v1
https://doi.org/10.20944/preprints202305.0075.v1
Autor:
Xiaojing Wang, Xiao Hu, Pan Diao, Naoki Tanaka, Kazuhiko Koike, Fangping Jia, Takefumi Kimura, Kyoji Moriya, Takero Nakajima, Toshifumi Aoyama
Publikováno v:
Engineering. 7:1797-1805
Hepatitis C virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC) worldwide. Among the structural proteins of HCV, the HCV core protein has the ability to regulate gene transcription, lipid metabolism,
Autor:
Yosuke Yamada, Kozo Nakamura, Naoki Tanaka, Yuji Kamijo, Takero Nakajima, Toshifumi Aoyama, Pan Diao, Jun Nakayama, Yaping Wang
Publikováno v:
The FASEB Journal. 34:9594-9614
Metabolic changes in sulfatides and other sulfated glycans have been related to various diseases, including Alzheimer's disease (AD). However, the importance of polyunsaturated fatty acids (PUFA) in sulfated lysosomal substrate metabolism and its rel
Autor:
Yoshiko Sato, Makoto Nakamuta, Xiao Hu, Naoki Tanaka, Fangping Jia, Pan Diao, Jun Nakayama, Kyoji Moriya, Frank J. Gonzalez, Takefumi Kimura, Saki Shirotori, Toshifumi Aoyama, Kazuhiko Koike, Xiaojing Wang, Ibuki Nakamura
Publikováno v:
Liver Cancer, Pp 1-20 (2020)
Liver Cancer
Liver Cancer
Background and Aims: Dietary restriction (DR) is a preventive strategy for obesity, metabolic syndrome, cardiovascular disease, and diabetes. Although an interconnection between obesity, metabolic syndrome, fatty liver, and hepatocellular carcinoma h